To date, more than 40 risk loci for AD have been identified by genome-wide association studies (GWASs), which have implicated amyloid-β (Aβ), tau, and lipid metabolism in the development of AD (Lambert et al., 2013; Kunkle et al., 2019). Here, MAPT is linked to Alzheimer disease.